Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer — Stella

Home/Advanced Solid Tumours/A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

View on ClinicalTrials.gov

Recruiting

Back to Advanced Solid Tumours trials

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United Kingdom

The Christie NHS Foundation Trust, Manchester

University Hospital Southampton NHS Foundation Trust, Southampton

Key details

Phase

Early testing / Safety & dosing

Sponsor

Cancer Research UK

Collaborators

UCB Biopharma SRL

Enrollment target

~167 participants

Started

July 2024

Primary completion

November 2029

Age range

18 Years and older

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.